Obstructive sleep apnea and cardiovascular disease

Masahiko Kato, Taro Adachi, Yuki Koshino, Virend Somers

Research output: Contribution to journalArticle

67 Citations (Scopus)

Abstract

Over the past few decades, sleep apnea has emerged as an important potential etiologic factor in a broad range of cardiac and vascular diseases. These disease conditions include hypertension, coronary artery disease, myocardial infarction, heart failure, and stroke. Recognition of the role of sleep apnea in clinical cardiology is also increasing in Japan. Although sleep apnea has been strongly linked to obesity in Western populations, in Japanese and other Asian populations there is evidence to indicate that sleep apnea may be prevalent even at lower levels of obesity. In this review we address the epidemiology of sleep apnea. Since sleep apnea includes the combined stresses of hypoxemia, apnea, and disrupted sleep, we also review briefly the potential disease mechanisms that may be activated as a consequence of sleep apnea. We further examine the role of sleep apnea in the pathophysiology and management of specific cardiovascular conditions. Overall, while the evidence of sleep apnea as a causal mechanism in cardiovascular disease is strong and increasing, definitive evidence of the etiologic role of sleep apnea has yet to be obtained. The evidence is most clear in patients with hypertension. Also remaining to be established is whether the treatment of sleep apnea prevents cardiac and vascular events. With regard to this question, although the available data strongly suggest that continuous positive airway pressure treatment is beneficial, randomized control trials are needed in order to confirm this.

Original languageEnglish (US)
Pages (from-to)1363-1370
Number of pages8
JournalCirculation Journal
Volume73
Issue number8
DOIs
StatePublished - Aug 2009

Fingerprint

Sleep Apnea Syndromes
Obstructive Sleep Apnea
Cardiovascular Diseases
Obesity
Hypertension
Continuous Positive Airway Pressure
Cardiology
Vascular Diseases
Population
Blood Vessels
Coronary Artery Disease
Heart Diseases
Japan
Epidemiology
Heart Failure
Stroke
Myocardial Infarction

Keywords

  • Atrial fibrillation
  • Heart failure
  • Sleep apnea

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Obstructive sleep apnea and cardiovascular disease. / Kato, Masahiko; Adachi, Taro; Koshino, Yuki; Somers, Virend.

In: Circulation Journal, Vol. 73, No. 8, 08.2009, p. 1363-1370.

Research output: Contribution to journalArticle

Kato, Masahiko ; Adachi, Taro ; Koshino, Yuki ; Somers, Virend. / Obstructive sleep apnea and cardiovascular disease. In: Circulation Journal. 2009 ; Vol. 73, No. 8. pp. 1363-1370.
@article{edb134ba8a934ec6a0048bfba51112b1,
title = "Obstructive sleep apnea and cardiovascular disease",
abstract = "Over the past few decades, sleep apnea has emerged as an important potential etiologic factor in a broad range of cardiac and vascular diseases. These disease conditions include hypertension, coronary artery disease, myocardial infarction, heart failure, and stroke. Recognition of the role of sleep apnea in clinical cardiology is also increasing in Japan. Although sleep apnea has been strongly linked to obesity in Western populations, in Japanese and other Asian populations there is evidence to indicate that sleep apnea may be prevalent even at lower levels of obesity. In this review we address the epidemiology of sleep apnea. Since sleep apnea includes the combined stresses of hypoxemia, apnea, and disrupted sleep, we also review briefly the potential disease mechanisms that may be activated as a consequence of sleep apnea. We further examine the role of sleep apnea in the pathophysiology and management of specific cardiovascular conditions. Overall, while the evidence of sleep apnea as a causal mechanism in cardiovascular disease is strong and increasing, definitive evidence of the etiologic role of sleep apnea has yet to be obtained. The evidence is most clear in patients with hypertension. Also remaining to be established is whether the treatment of sleep apnea prevents cardiac and vascular events. With regard to this question, although the available data strongly suggest that continuous positive airway pressure treatment is beneficial, randomized control trials are needed in order to confirm this.",
keywords = "Atrial fibrillation, Heart failure, Sleep apnea",
author = "Masahiko Kato and Taro Adachi and Yuki Koshino and Virend Somers",
year = "2009",
month = "8",
doi = "10.1253/circj.CJ-09-0364",
language = "English (US)",
volume = "73",
pages = "1363--1370",
journal = "Circulation Journal",
issn = "1346-9843",
publisher = "Japanese Circulation Society",
number = "8",

}

TY - JOUR

T1 - Obstructive sleep apnea and cardiovascular disease

AU - Kato, Masahiko

AU - Adachi, Taro

AU - Koshino, Yuki

AU - Somers, Virend

PY - 2009/8

Y1 - 2009/8

N2 - Over the past few decades, sleep apnea has emerged as an important potential etiologic factor in a broad range of cardiac and vascular diseases. These disease conditions include hypertension, coronary artery disease, myocardial infarction, heart failure, and stroke. Recognition of the role of sleep apnea in clinical cardiology is also increasing in Japan. Although sleep apnea has been strongly linked to obesity in Western populations, in Japanese and other Asian populations there is evidence to indicate that sleep apnea may be prevalent even at lower levels of obesity. In this review we address the epidemiology of sleep apnea. Since sleep apnea includes the combined stresses of hypoxemia, apnea, and disrupted sleep, we also review briefly the potential disease mechanisms that may be activated as a consequence of sleep apnea. We further examine the role of sleep apnea in the pathophysiology and management of specific cardiovascular conditions. Overall, while the evidence of sleep apnea as a causal mechanism in cardiovascular disease is strong and increasing, definitive evidence of the etiologic role of sleep apnea has yet to be obtained. The evidence is most clear in patients with hypertension. Also remaining to be established is whether the treatment of sleep apnea prevents cardiac and vascular events. With regard to this question, although the available data strongly suggest that continuous positive airway pressure treatment is beneficial, randomized control trials are needed in order to confirm this.

AB - Over the past few decades, sleep apnea has emerged as an important potential etiologic factor in a broad range of cardiac and vascular diseases. These disease conditions include hypertension, coronary artery disease, myocardial infarction, heart failure, and stroke. Recognition of the role of sleep apnea in clinical cardiology is also increasing in Japan. Although sleep apnea has been strongly linked to obesity in Western populations, in Japanese and other Asian populations there is evidence to indicate that sleep apnea may be prevalent even at lower levels of obesity. In this review we address the epidemiology of sleep apnea. Since sleep apnea includes the combined stresses of hypoxemia, apnea, and disrupted sleep, we also review briefly the potential disease mechanisms that may be activated as a consequence of sleep apnea. We further examine the role of sleep apnea in the pathophysiology and management of specific cardiovascular conditions. Overall, while the evidence of sleep apnea as a causal mechanism in cardiovascular disease is strong and increasing, definitive evidence of the etiologic role of sleep apnea has yet to be obtained. The evidence is most clear in patients with hypertension. Also remaining to be established is whether the treatment of sleep apnea prevents cardiac and vascular events. With regard to this question, although the available data strongly suggest that continuous positive airway pressure treatment is beneficial, randomized control trials are needed in order to confirm this.

KW - Atrial fibrillation

KW - Heart failure

KW - Sleep apnea

UR - http://www.scopus.com/inward/record.url?scp=69149089848&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=69149089848&partnerID=8YFLogxK

U2 - 10.1253/circj.CJ-09-0364

DO - 10.1253/circj.CJ-09-0364

M3 - Article

C2 - 19564701

AN - SCOPUS:69149089848

VL - 73

SP - 1363

EP - 1370

JO - Circulation Journal

JF - Circulation Journal

SN - 1346-9843

IS - 8

ER -